Structure of Dovitinib
CAS No.: 405169-16-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Dovitinib is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM.
Synonyms: CHIR-258; TKI258
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 405169-16-6 |
| Formula : | C21H21FN6O |
| M.W : | 392.43 |
| SMILES Code : | CN1CCN(CC1)C2=CC3=C(N=C(N3)C4=C(C5=C(NC4=O)C=CC=C5F)N)C=C2 |
| Synonyms : |
CHIR-258; TKI258
|
| MDL No. : | MFCD10565680 |
| InChI Key : | PIQCTGMSNWUMAF-UHFFFAOYSA-N |
| Pubchem ID : | 135398510 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H302-H315-H319-H335 |
| Precautionary Statements: | P261-P305+P351+P338 |
| Target |
|
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT00279773 | Acute Myeloid Leukemia | PHASE1 | TERMINATED | - | The University of Texas, M.D. ... More >>Anderson Cancer Center, Houston, Texas, 77020, United States Less << |
| NCT01972750 | First or Second Recurrence of ... More >>Glioblastoma Less << | PHASE1 | UNKNOWN | 2025-11-16 | Department of Neurology and Ce... More >>nter of Integrated Oncology, University Hospital Bonn, Bonn, 53105, Germany Less << |
| NCT00303251 | Melanoma | PHASE1|PHASE2 | COMPLETED | - | James Graham Brown Cancer Cent... More >>er, Louisville, Kentucky, 40202, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15232, United States|MD Anderson Cancer, Houston, Texas, 77030, United States Less << |
| NCT00790426 | Urothelial Cancer | PHASE2 | COMPLETED | 2025-04-12 | University of California San D... More >>iego - Moores Cancer Center UCSD, La Jolla, California, 92093-0658, United States|USC/Kenneth Norris Comprehensive Cancer Center Regulatory Contact 3, Los Angeles, California, 90053, United States|University Chicago Hospital CTKI258A2201, Chicago, Illinois, 60637, United States|Dana Farber Cancer Institute Dana 1230, Boston, Massachusetts, 02215, United States|Nevada Cancer Institute Nevada Cancer Institute, Las Vegas, Nevada, 89135, United States|Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering (2), New York, New York, 10065, United States|Duke University Medical Center Dept.ofDukeUniversityMedCtr(2), Durham, North Carolina, 27710, United States|The West Clinic, Memphis, Tennessee, 38120, United States|Novartis Investigative Site, Vienna, 1100, Austria|Novartis Investigative Site, Victoria, British Columbia, V8R 6V5, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Berlin, 10098, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Roma, RM, 00152, Italy|Novartis Investigative Site, Sevilla, Andalucia, 41013, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08003, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Barcelona, 08041, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Madrid, 28050, Spain|Novartis Investigative Site, Tainan 704, Taiwan ROC, Taiwan|Novartis Investigative Site, Taipei, 10048, Taiwan|Novartis Investigative Site, Leeds, West Yorkshire, LS9 7TF, United Kingdom|Novartis Investigative Site, Southampton, SO16 6YD, United Kingdom Less << |
| NCT00669097 | Advanced Solid Malignancies | PHASE1 | COMPLETED | - | Novartis Investigative Site, A... More >>msterdam, Netherlands Less << |
| NCT01791387 | Clear Cell Renal Cell Carcinom... More >>a Less << | PHASE2 | UNKNOWN | 2025-06-15 | Auckland Hospital, Auckland, 1... More >>142, New Zealand Less << |
| NCT01732107 | Bladder Cancer | PHASE2 | TERMINATED | 2017-03-06 | Indiana University Melvin and ... More >>Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|Fox Chase Cancer Center Extramural Research Program, Rockledge, Pennsylvania, 19046, United States Less << |
| NCT01678105 | Recurrent Adenoid Cystic Carci... More >>noma of the Salivary Glands|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|Salivary Gland Cancers|ACC Less << | PHASE2 | COMPLETED | 2025-09-15 | Tom Baker Cancer Centre, Calga... More >>ry, Ontario, T2N 4N2, Canada|Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada|London Health Sciences Centre, London, Ontario, N6A 4L6, Canada|Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada Less << |
| NCT01741116 | Hormone Refractory Prostate Ca... More >>ncer Less << | PHASE2 | COMPLETED | 2025-10-16 | Korean Cancer Study Group, Seo... More >>ul, Chongro-ku, 110999, Korea, Republic of|Korea University Anam Hospital, Seoul, Seongbuk-gu, Inchon-ro, 136-705, Korea, Republic of Less << |
| NCT01058434 | Relapsed or Refractory Multipl... More >>e Myeloma Less << | PHASE2 | COMPLETED | 2025-02-13 | University of South Alabama / ... More >>Mitchell Cancer Institute Dept. of Mitchell Cancer Inst., Mobile, Alabama, 36688, United States|Central Hematology Oncology Medical Group, Alhambra, California, 91801, United States|Central Coast Medical Oncology Corporation, Santa Maria, California, 93454, United States|St. Jude Heritage Medical Group Virginia Crosson Cancer Center, Yorba Linda, California, 92886, United States|Kootenai Medical Center Kootenai Medical Center, Coeur d'Alene, Idaho, 83814, United States|Hematology and Oncology Specialists Dept of Hem&Onc Specialist - 2, Metairie, Louisiana, 70006, United States|Mayo Clinic - Rochester Rochester, Rochester, Minnesota, 55905, United States|Memorial Sloan Kettering Cancer Center MSKCC, New York, New York, 10021, United States|Duke University Medical Center Dept. of DUMC (4), Durham, North Carolina, 27710, United States|Lancaster Cancer Center, Lancaster, Pennsylvania, 17601, United States|Cancer Centers of the Carolinas Dept. of CC of the Carolinas, Greenville, South Carolina, 29605, United States|University of Tennessee Cancer Institute SC-2, Memphis, Tennessee, 38104, United States|University of Texas Southwestern Medical Center UTSW Medical Center, Dallas, Texas, 75390-8527, United States|University of Wisconsin SC, Madison, Wisconsin, 53792, United States|Medical College of Wisconsin Med College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Melbourne, Victoria, 3002, Australia|Novartis Investigative Site, Prahran, Victoria, 3181, Australia|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Montreal, Quebec, H3A 1A1, Canada|Novartis Investigative Site, Nantes Cedex 1, 44093, France|Novartis Investigative Site, Bochum, 44892, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, K?ln, 50924, Germany|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Rotterdam, 3015 CE, Netherlands|Novartis Investigative Site, Rotterdam, 3075 EA, Netherlands|Novartis Investigative Site, Altunizade, 34662, Turkey|Novartis Investigative Site, Ankara, 06100, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey Less << |
| NCT01576380 | Adenocarcinoma, Scirrhous|Lini... More >>tis Plastica|Stomach Neoplasms|Stomach Diseases|Neoplasms by Site|Neoplasms Less << | PHASE2 | COMPLETED | 2025-09-13 | Novartis Investigative Site, N... More >>agoya, Aichi, 464-8681, Japan|Novartis Investigative Site, Kashiwa, Chiba, 277-8577, Japan|Novartis Investigative Site, Matsuyama, Ehime, 791-0280, Japan|Novartis Investigative Site, Sapporo-city, Hokkaido, 060-8648, Japan|Novartis Investigative Site, Takatsuki, Osaka, 569-8686, Japan|Novartis Investigative Site, Sunto-gun, Shizuoka, 411-8777, Japan|Novartis Investigative Site, Chuo-ku, Tokyo, 104-0045, Japan|Novartis Investigative Site, Koto, Tokyo, 135-8550, Japan Less << |
| NCT01514526 | Adrenocortical Carcinoma | PHASE2 | COMPLETED | 2025-11-16 | Complejo Hospitalario Universi... More >>tario de Santiago, Santiago de Compostela, A Coru?a, 15706, Spain|Hospital Universitario Fundación de Alcorcón, Alcorcón, Madrid, 28922, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario Reina Sofía, Córdoba, 14004, Spain|Hospital Universitario Central de Asturias, Oviedo, 33006, Spain|Complejo Hospitalario de Navarra, Pamplona, 31008, Spain|Fundación Instituto Valenciano de Oncología, Valencia, 46009, Spain Less << |
| NCT01471548 | Advanced Solid Tumors | PHASE1 | COMPLETED | 2025-05-12 | Novartis Investigative Site, T... More >>akatsuki, Osaka, 569-8686, Japan|Novartis Investigative Site, Hidaka, Saitama, 350-1241, Japan Less << |
| NCT01379534 | Solid Tumors and Advanced Endo... More >>metrial Cancer|Endometrial Cancer|Second-line Treatment|VEGF Less << | PHASE2 | COMPLETED | 2025-03-14 | University of South Alabama / ... More >>Mitchell Cancer Institute Univ South Alabama, Mobile, Alabama, 36688, United States|St. Jude Heritage Medical Group St Jude, Fullerton, California, 92835, United States|USC/Kenneth Norris Comprehensive Cancer Center USC 2, Los Angeles, California, 90033, United States|Cedars Sinai Medical Center TKI258A2211 (SC), Los Angeles, California, 90048, United States|University of California at Los Angeles UCLA 3, Los Angeles, California, 90095, United States|Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer, Greenwood Village, Colorado, United States|Florida Hospital Cancer Institute FL Hosp, Orlando, Florida, 32804, United States|Indiana University Health Goshen Center for Cancer IU Simon Cancer, Indianapolis, Indiana, 46202, United States|University of Iowa Hospitals & Clinics SC, Iowa City, Iowa, 52242, United States|Dana Farber Cancer Institute SC, Boston, Massachusetts, 02115, United States|Southeast Nebraska Oncology Cancer Center, Lincoln, Nebraska, 68510, United States|Hope A Woman's Cancer Center, Asheville, North Carolina, 28806, United States|Duke University Medical Center Duke3, Durham, North Carolina, 27710, United States|Community Oncology Research Network, Chattanooga, Tennessee, 37403, United States|The West Clinic SC, Memphis, Tennessee, 38120, United States|Texas Oncology, P.A. Austin, Bedford, Texas, 76022, United States|Texas Oncology, P.A. Tex Onc (3), Bedford, Texas, 76022, United States|Texas Oncology, P.A. SC, Fort Worth, Texas, 76104, United States|South Texas Oncology and Hematology, PA South Tex Onc, San Antonio, Texas, 78258, United States|Virginia Oncology Associates VOA - Lake Wright, *see Various Departments*, Virginia, United States|Cancer Care Northwest SC, Spokane, Washington, 99202, United States|Novartis Investigative Site, Belo Horizonte, MG, 30150-270, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90610-000, Brazil|Novartis Investigative Site, Ribeirao Preto, SP, 14048-900, Brazil|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Monza, MB, 20900, Italy|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Pisa, PI, 56126, Italy|Novartis Investigative Site, Roma, RM, 00168, Italy|Novartis Investigative Site, Candiolo, TO, 10060, Italy|Novartis Investigative Site, Seoul, Korea, 135-710, Korea, Republic of|Novartis Investigative Site, Seoul, 738-736, Korea, Republic of|Novartis Investigative Site, Grafton, Auckland, New Zealand|Novartis Investigative Site, Cordoba, Andalucia, 14004, Spain|Novartis Investigative Site, Málaga, Andalucia, 29010, Spain|Novartis Investigative Site, Oviedo, Asturias, 33006, Spain|Novartis Investigative Site, Sabadell, Barcelona, 08208, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Majadahonda, Madrid, 28222, Spain|Novartis Investigative Site, Murcia, 30008, Spain|Novartis Investigative Site, Glasgow, G12 0YN, United Kingdom|Novartis Investigative Site, Leeds, LS9 7TF, United Kingdom|Novartis Investigative Site, London, NW1 2BU, United Kingdom|Novartis Investigative Site, Nottingham, NG5 1PB, United Kingdom Less << |
| NCT01443481 | Solid Tumors|Hepatic Impairmen... More >>t Less << | PHASE1 | COMPLETED | 2025-10-14 | University of California at Lo... More >>s Angeles Dept. of UCLA (4), Los Angeles, California, 90095, United States|Duke University Medical Center DUMC, Durham, North Carolina, 27710, United States|Cancer Therapy & Research Center / UT Health Science Center SC, San Antonio, Texas, 78229, United States|Novartis Investigative Site, Gent, 9000, Belgium|Novartis Investigative Site, Frankfurt, 60590, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Rozzano, MI, 20089, Italy|Novartis Investigative Site, Verona, VR, 37126, Italy|Novartis Investigative Site, Amsterdam, 1066 CX, Netherlands|Novartis Investigative Site, Maastricht, 5800, Netherlands|Novartis Investigative Site, Singapore, 119228, Singapore Less << |
| NCT01861197 | Squamous NSCLC | PHASE2 | UNKNOWN | - | Samsung Medical Center, Seoul,... More >> 135-710, Korea, Republic of Less << |
| NCT01964144 | Thyroid Cancer | PHASE2 | COMPLETED | 2025-10-14 | Division of Medical Oncology, ... More >>Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, 120-752, Korea, Republic of Less << |
| NCT00715182 | Advanced/ Metastatic Renal Cel... More >>l Cancer Less << | PHASE1 | COMPLETED | 2025-07-12 | Novartis Investigative Site, S... More >>an Francisco, California, United States|Novartis Investigative Site, Durham, North Carolina, 27710, United States|Novartis Investigative Site, Seattle, Washington, 98109-1023, United States|Novartis Investigative Site, Bordeaux Cedex, 33075, France|Novartis Investigative Site, Villejuif Cedex, 94805, France|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, München, 81675, Germany|Novartis Investigative Site, Rotterdam, 3075 EA, Netherlands|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Taipei, Taiwan, ROC, 112, Taiwan|Novartis Investigative Site, Taichung, 40705, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan Less << |
| NCT01635907 | Advanced Metastatic Paragangli... More >>oma|Advanced Metastatic Pheochromocytoma|Recurrent Paraganglioma|Recurrent Pheochromocytoma|Unresectable Paraganglioma|Unresectable Pheochromocytoma Less << | PHASE2 | COMPLETED | 2016-04-11 | Abramson Cancer Center of the ... More >>University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less << |
| NCT01262027 | Breast Cancer | PHASE2 | COMPLETED | 2015-11-25 | University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less << |
| NCT00958971 | Metastatic Breast Cancer | PHASE2 | COMPLETED | 2025-03-11 | Comprehensive Blood and Cancer... More >> Center Dept CBCC (3), Bakersfield, California, 93309, United States|Tower Cancer Research, Beverly Hills, California, 90211, United States|UCLA/ University of California Los Angeles Div. of Hematology/Oncology, Los Angeles, California, 90095, United States|Cancer Care Associates Medical Group Dept. of CCA, Redondo Beach, California, 90277, United States|Central Coast Medical Oncology Corporation, Santa Maria, California, 93454, United States|Florida Cancer Specialists Dept.of FloridaCancerSpec. (2), Fort Myers, Florida, 33901, United States|Kansas City Cancer Center KCCC (3), Overland Park, Kansas, 66210, United States|Associates in Oncology/Hematology, P.C., Rockville, Maryland, 20850, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, 89052, United States|UNC/ Lineberger Comprehensive Cancer Center Dept. of Linberger Cancer Ctr, Chapel Hill, North Carolina, 27599-7295, United States|Northwest Cancer Specialists Northwest Office (2), Portland, Oregon, 97210, United States|Texas Oncology, P.A. Dept. of Texas Oncology, Bedford, Texas, 76022, United States|Texas Oncology, P.A. Austin, Dallas, Texas, 75246, United States|Texas Oncology, P.A. Presbyterian Hospital, Dallas, Texas, 75246, United States|Texas Oncology, P.A. Texas Oncology - Sammons, Dallas, Texas, 75246, United States|Tyler Cancer Center Dept.ofTylerCancerCtr. (2), Tyler, Texas, 75702, United States|Fairfax Northern Virginia Hematology Oncology Fairfax NVH, Fairfax, Virginia, 22031, United States|Blue Ridge Research Center at Roanoke Neurological Center Blue Ridge Cancer Care, Roanoke, Virginia, 24014, United States|Novartis Investigative Site, Edmonton, Alberta, T6G 1Z2, Canada|Novartis Investigative Site, Montreal, Quebec, H2W 1T8, Canada|Novartis Investigative Site, Helsinki, FIN-00029, Finland|Novartis Investigative Site, Lyon Cedex, 69373, France|Novartis Investigative Site, Saint-Herblain Cédex, 44805, France|Novartis Investigative Site, Toulouse Cedex 3, 31052, France|Novartis Investigative Site, Villejuif Cedex, 94805, France|Novartis Investigative Site, Cuneo, CN, 12100, Italy|Novartis Investigative Site, Cremona, CR, 26100, Italy|Novartis Investigative Site, Parma, PR, 43100, Italy|Novartis Investigative Site, Candiolo, TO, 10060, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Negrar, 37024, Italy|Novartis Investigative Site, Barcelona, Catalu?a, 08035, Spain|Novartis Investigative Site, Lleida, Catalu?a, 25198, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Taipei, 10048, Taiwan|Novartis Investigative Site, Glasgow, G12 0YN, United Kingdom|Novartis Investigative Site, London, SE1 9RT, United Kingdom|Novartis Investigative Site, London, SW3 6JJ, United Kingdom Less << |
| NCT00243763 | Multiple Myeloma | PHASE1 | TERMINATED | - | Mayo Clinic - Arizona, Scottsd... More >>ale, Arizona, 85259, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States|Emory University, Atlanta, Georgia, 30322, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Mayo Clinic - Minnesota, Rochester, Minnesota, 55905, United States Less << |
| NCT01266070 | Von Hippel-Lindau Syndrome | PHASE2 | TERMINATED | 2025-12-15 | University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less << |
| NCT01421004 | Advanced Solid Tumors|Excludin... More >>g Breast Cancer Less << | PHASE1 | COMPLETED | 2025-07-14 | City of Hope National Medical ... More >>Center SC-2, Duarte, California, 91010-3000, United States|University of California at Los Angeles UCLA LeConte Location, Los Angeles, California, 90095, United States|University of California San Francisco UCSF (SC), San Francisco, California, 94101, United States|Florida Cancer Specialists Sarasota Office, Fort Myers, Florida, 33901, United States|Rush University Medical Center Rush 3, Chicago, Illinois, 60612, United States|Washington University School of Medicine SC, Saint Louis, Missouri, 63110, United States|Montefiore Medical Center Montefiore Medical Center (SC), Bronx, New York, 10467, United States|University of Oklahoma Health Sciences Center OUHSC - SC, Oklahoma City, Oklahoma, 73104, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15232-1305, United States|Sarah Cannon Research Institute Sarah Cannon Research (SC), Nashville, Tennessee, 37203, United States|Sammons Cancer Center - Texas Oncology SC-2, Dallas, Texas, 78246, United States|Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5), San Antonio, Texas, 78229, United States|University of Utah / Huntsman Cancer Institute Huntsman, Salt Lake City, Utah, 84112, United States|University of Wisconsin Univ Wisc, Madison, Wisconsin, 53792, United States Less << |
| NCT01676714 | Non-Small Cell Lung Cancer|Col... More >>orectal Cancer Less << | PHASE2 | COMPLETED | 2025-06-16 | University of California Compr... More >>ehensive Cancer Center, Sacramento, California, 95817, United States Less << |
| NCT01769547 | Advanced Malignant Pleural Mes... More >>othelioma|MPM Less << | PHASE2 | TERMINATED | 2025-06-15 | Tom Baker Cancer Centre, Calga... More >>ry, Alberta, T2N 4N2, Canada|Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada|Ottawa General Hospital Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada|Northeast Cancer Centre, Health Sciences North, Sudbury, Ontario, P3E 5J1, Canada|Princess Margaret Hospital, Toronto, Ontario, M5G 1X6, Canada Less << |
| NCT01888965 | Colorectal Cancer|Pancreas Can... More >>cer Less << | PHASE2 | TERMINATED | 2025-10-14 | Georgetown University- Lombard... More >>i Cancer Center, Washington, District of Columbia, 20007, United States Less << |
| NCT01155713 | Neoplasm|Cancer|Tumors | PHASE1 | COMPLETED | 2025-11-13 | Scottsdale Healthcare/TGen Cli... More >>nical Research Service TGen Clinical Research Service, Scottsdale, Arizona, 85258, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Sarah Cannon Research Institute Sarah Cannon Research Instit, Nashville, Tennessee, 37203, United States|University of Utah / Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States Less << |
| NCT01719549 | Gastric Cancer | PHASE2 | COMPLETED | 2025-11-16 | Asan Medical Center, Seoul, 13... More >>8-736, Korea, Republic of Less << |
Tags: Dovitinib | CHIR-258 | TKI258 | CHIR258 | CHIR 258 | TKI258 | TKI 258 | TKI-258 | FLT3 | c-Kit | FGFR | VEGFR | PDGFR | c-Fms | Cluster of differentiation antigen 135 | CD135 | Fms like tyrosine kinase 3 | SCFR | CD117 | Fibroblast growth factor receptor | Vascular endothelial growth factor receptor | Platelet-derived growth factor receptor | CSF-1 receptor | colony stimulating factor 1 receptor | CSF-1R | CSF1R | orally | RTK | KMS11 | OPM2 | KMS18 | 405169-16-6
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


